App-based home-monitoring for Covid-19 patients

• Conditions: 07.1; U07.1; COVID-19, virus identified

• Registration Number: DRKS00024604
• Lead Sponsor: niversitätsklinikum Frankfurt, Medizinische Klinik 1

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-26
• Study Completion: 2021-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

positiv PCR Test SARS-CoV-2

Exclusion Criteria

No access to a smartphone; pregnancy (only Aachen)

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The use of the digital health application improves the treatment management of Covid-19 patients by<br>1. regularly recording vital signs and symptoms <br>2. collection of patient reported outcomes<br>3. exchange of data and information patients and physicians.<br><br>Assessment via questionnaires on usability / user acceptance (patients and physicians); qualitative interviews on usability / user acceptance (patients and physicians); EQ-5D-3L: Health-related quality of life; Psychological Screening (PHQ-4, PTTS-10); assessment of current symptoms, relevant previous illnesses, medication plan; vital signs (pulse, blood pressure, body temperature, oxygen saturation) in the acute phase; parameters of lung function (FVC, FEV1, peak flow) and activity data (number of steps) in the post-acute / rehabilitation phase

Secondary Outcome Measures

Name	Time	Method
The use of the digital health application increases patient sovereignty.<br><br>The use of the digital health application improves shared decision-making between doctor and patient.<br><br>The use of the digital health application increases patient safety.<br><br>The use of the digital health application improves the alignment of treatment with guidelines and recognized standards.<br><br>Evaluation by the same parameters as the primary endpoint.